With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.142-71-2,Copper(II) acetate,as a common compound, the synthetic route is as follows.,142-71-2
A mixture of 0.04 g (0.065 mmol) of porphin 1 and 0.118 g (0.65 mmol) of Cu(OAc)2 in 40 mL of dimethylformamide was heated under reflux for 15 s. The reaction mixture was cooled, water and solid NaCl was added, the precipitate was separated by filtration, washed with water, dried, and chromatographed on aluminum oxide using chloroform as an eluent to give 0.038 g (0.0562 mmol) (86%) of compound 5. MS (m/z (Irel, %)): 675 (97) [M]+; for C44H28N4Cu calcd.: 676. IR (nu, cm-1): 2926 s, 2855 m nu(C-H, Ph), 1694 w,1598 m 1489 s nu(C=C, Ph), 1441 m nu(C=N), 1371 m, 1346 s nu(C-N), 1146 s, 1071 s delta(C-H, Ph), 1005 s nu(C-C), 861 m, 794 m gamma(C-H, pyrrole ring), 742 m, 696 m gamma(C-H, h), 480 nu(Cu-N).
142-71-2 Copper(II) acetate 8895, acopper-catalyst compound, is more and more widely used in various.
Reference£º
Article; Chizhova; Shinkarenko; Zav?yalov; Mamardashvili, N. Zh.; Russian Journal of Inorganic Chemistry; vol. 63; 6; (2018); p. 732 – 735; Zh. Neorg. Khim.; vol. 63; 6; (2018); p. 695 – 699,5;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”